Effect of Whatsapp messaging for patient follow up on clinical outcomes of patients with type 2 diabetes

Not Applicable

Recruiting

• Conditions: E11; Type 2 diabetes mellitus

• Registration Number: DRKS00019882
• Lead Sponsor: King Saud University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-12-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

• Age between 18–60 years
• Diagnosed with type 2 diabetes
• HbA1c > 8% during screening
• Patients who have their own mobile phones and ability to use a mobile phone;
• No chronic complications associated with incapacity
• Willing to use Whatsapp messaging service

Exclusion Criteria

• Pregnancy
• Type 1 diabetes
• Any condition that will impair smartphone use

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in the HbA1c levels of the patients from baseline to end of the study is the primary endpoint of this study. Blood samples will be collected from the patients at baseline and at the end of the study to estimate the HbA1c levels.

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints include changes in the fasting blood glucose, lipid profile and body weight from baseline values. Blood samples will be collected from the patients at baseline and at the end of the study to estimate these parameters.